Although NAMPT is an enzyme in the NAD+ salvage pathway, proteomic profiles of proteins involved in NAD+ metabolism in IBD patients show that it is pro-inflammatory and tumorigenic [59]. The gene discussed is NAMPT; the disease is inflammatory bowel disease.